Abstract
The BCL-2 anti-apoptotic proteins are over-expressed in many cancers and hence are attractive therapeutic targets. In this study, we tested the sensitivity of two Nasopharyngeal Carcinoma (NPC) cell lines HK1 and C666-1 to Maritoclax, which is reported to repress anti-apoptotic protein MCL-1 and BH3 mimetic ABT-263, which selectively inhibits anti-apoptotic proteins BCL-2, BCL-XL and BCL-w. We investigated the sensitisation of the NPC cell lines to these drugs using the SYBR Green I assay and 3D NPC spheroids. We report that Maritoclax repressed anti-apoptotic proteins MCL-1, BCL-2, and BCL-XL in a dose- and time-dependent manner and displayed a single agent activity in inhibiting cell proliferation of the NPC cell lines. Moreover, combination of Maritoclax and ABT-263 exhibited synergistic antiproliferative effect in the HK1 cells. Similar results were obtained in the 3D spheroids generated from the HK1 cells. More notably, 3D HK1 spheroids either treated with single agent Maritoclax or combination with ABT-263, over 10 days, did not develop resistance to the treatment rapidly. Collectively, the findings illustrate that Maritoclax as a single agent or combination with BH3 mimetics could be potentially useful as treatment strat...Continue Reading
References
Jan 1, 1984·Advances in Enzyme Regulation·T C Chou, P Talalay
May 1, 1997·Human Pathology·L F SheuW H Lee
Dec 17, 2003·Archives of Otolaryngology--head & Neck Surgery·Yongqiang YuShuhua Li
May 2, 2006·Human Pathology·Song-Qing FanGui-Yuan Li
May 30, 2006·Molecular Cancer Therapeutics·Keiran S M SmalleyMeenhard Herlyn
Sep 14, 2006·Pharmacological Reviews·Ting-Chao Chou
Jan 22, 2008·Organic Letters·Chambers C HughesWilliam Fenical
Apr 30, 2008·Head & Neck·Mu-Kuan ChenHui-Chuan Chen
May 3, 2008·Cancer Research·Christin TseSteven W Elmore
Aug 14, 2009·Journal of the American Chemical Society·Chambers C HughesWilliam Fenical
Dec 29, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mu-Kuan ChenHui-Chuan Chen
Jun 16, 2011·PloS One·Eileen M McGowanRosetta Martinello-Wilks
Dec 17, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Keryn M LucasJohn D Allen
Feb 9, 2012·The Journal of Biological Chemistry·Kenichiro DoiHong-Gang Wang
Jul 20, 2012·Cancer Cell International·Maelinda DakerAlan Sb Khoo
Jan 1, 2008·Expert Opinion on Drug Discovery·Keiran Sm SmalleyMeenhard Herlyn
Oct 26, 2013·Cell Death & Disease·J M EichhornT C Chambers
Nov 14, 2013·PloS One·Manoj K PandeyShantu Amin
May 21, 2014·Cancer Biology & Therapy·Kenichiro DoiHong-Gang Wang
Mar 20, 2015·Science Translational Medicine·Joel D LeversonAndrew J Souers
Jun 11, 2015·Oncotarget·Shankar VaradarajanGerald M Cohen
Nov 18, 2015·Cancer Biology & Therapy·Wataru NakajimaHisashi Harada
Nov 21, 2015·The Journal of Pharmacology and Experimental Therapeutics·Esther P JaneIan Pollack
Dec 2, 2015·Oncotarget·Kelly AiriauFrançois-Xavier Mahon
Oct 28, 2017·Cell Death and Differentiation·Joan Montero, Antony Letai
Mar 28, 2018·BMC Research Notes·Benedict Shi Xiang LianNethia Mohana-Kumaran
Sep 13, 2018·CA: a Cancer Journal for Clinicians·Freddie BrayAhmedin Jemal
Jan 1, 2018·Cell Death and Differentiation·Joan Montero, Antony Letai